跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,958 条关于
“Cellenkos Inc.”
全部
40,958
临床试验
11,201
药物
1,598
机构
6,168
资讯
21,991
去年
KFSHRC and Cellenkos Partner to Advance Treg Cell Therapies for Rare Diseases in Landmark Saudi-US Collaboration
27天前
Cellenkos Receives FDA Fast Track Designation for CK0803 in Amyotrophic Lateral Sclerosis
去年
Texas A&M Researcher's Umbilical Cord Cell Therapy Shows Promise for ALS Treatment in Clinical Trials
去年
Cellenkos' Novel Off-The-Shelf Treg Cell Therapy Demonstrates Promising Results in ALS Clinical Study
4个月前
Cellenkos Receives FDA Clearance for Phase 2 Trial of CK0801 Allogeneic Treg Therapy in Aplastic Anemia
去年
FDA Grants Orphan Drug Designation to Cellenkos' CK0801 for Aplastic Anemia Treatment
9个月前
Cellenkos' CK0804 Regulatory T Cell Therapy Shows Promise in JAK Inhibitor-Resistant Myelofibrosis
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
第 1 页,共 2200 页
上一页
下一页